Calithera Biosciences to Report Second Quarter 2017 Financial Results on Tuesday, August 8, 2017
Aug 02, 2017 11:00 am UTC| Business
SOUTH SAN FRANCISCO, Calif., Aug. 02, 2017 -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor...
Dirk Van de Put to Become CEO of Mondelēz International as Long-time CEO Irene Rosenfeld Retires
Aug 02, 2017 11:00 am UTC| Business
Transition Effective November 2017Rosenfeld to Continue as Chairman until March 31, 2018 DEERFIELD, Ill., Aug. 02, 2017 -- Mondelēz International (NASDAQ:MDLZ) today announced that its Board of Directors has...
Mondelēz International Reports Q2 Results and Increases Quarterly Dividend
Aug 02, 2017 11:00 am UTC| Business
Operating income margin was 10.7%, up 60 basis points; Adjusted Operating Income1 margin was 15.8%, up 90 basis pointsDiluted EPS was $0.32, up 10%; Adjusted EPS1 was $0.48, up 19% on a constant-currency basisNet revenues...
Aug 02, 2017 11:00 am UTC| Business
New York, Aug. 02, 2017 -- PeerIQ, a leading provider of data and analytics for the lending sector, today announced that it has closed a $12 million Series A funding round, co-led by TransUnion, Hearst’s Financial...
SynTech Bioenergy Announces Japan Distributorship
Aug 02, 2017 11:00 am UTC| Business
DENVER, Aug. 02, 2017 -- SynTech Bioenergy, a Denver-based renewable energy technology company, has officially announced the formation of its Japanese Distributorship in Tokyo, Japan under the name SynTech Japan Co,...
Manhattan Bridge Capital, Inc. Declares Quarterly Dividend
Aug 02, 2017 11:00 am UTC| Business
GREAT NECK, N.Y., Aug. 02, 2017 -- Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) announced today that its board of directors has authorized a quarterly dividend of $0.1025 per share to be paid to all shareholders of...
Cyclacel Pharmaceuticals to Release Second Quarter 2017 Financial Results
Aug 02, 2017 11:00 am UTC| Business
BERKELEY HEIGHTS, N.J., Aug. 02, 2017 -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target the various phases of...